A new vaccine being trialled on Oxfordshire children could help in the fight against meningitis.
Teenagers at four of the county’s schools have been enlisted by Oxford University to trial the new group B meningococcal (MenB) vaccine to test whether it can reduce carriage of the bacteria.
Bacteria at the back of the throat can cause meningitis and the study will look at whether vaccination can stop this happening.
There are 2,000 students aged 16-18 taking part in the trial, organised by Oxford Vaccine Group, across Oxfordshire, Berkshire and Buckinghamshire.
They will be given the MenB-fHBP (Trumenba) vaccine, while a further 22,000 teenagers around the UK will trial this or 4CMenB (Bexsero).
The National Institute for Health Research is helping to run and fund the Be On The Team trial.
Dr Matthew Snape, of Oxford Vaccine Group, said: “Participants will not only get a vaccine that reduces their risk of meningitis but also help us understand if we can prevent the bug being carried and potentially spread to others.”
The Oxfordshire schools involved are Cheney School, Oxford; Tudor Hall School, Banbury; Our Lady’s Abingdon and King Alfred’s Academy, Wantage.